Estee Lauder Cos ( EL) pushed the Consumer Goods sector lower today making it today's featured Consumer Goods loser. The sector as a whole closed the day down 0.1%. By the end of trading, Estee Lauder Cos fell $1.34 (-2%) to $64.01 on average volume. Throughout the day, 1.8 million shares of Estee Lauder Cos exchanged hands as compared to its average daily volume of two million shares. The stock ranged in price between $63.94-$65.48 after having opened the day at $65.43 as compared to the previous trading day's close of $65.35. Other company's within the Consumer Goods sector that declined today were: Exceed Company ( EDS), down 14.3%, Swisher Hygiene ( SWSH), down 12.9%, Bridgford Foods Corporation ( BRID), down 9.9%, and Nu Skin ( NUS), down 8.3%. The Estee Lauder Companies Inc. engages in the manufacture, marketing, and sale of skin care, makeup, fragrance, and hair care products worldwide. Estee Lauder Cos has a market cap of $15.39 billion and is part of the consumer non-durables industry. The company has a P/E ratio of 30.9, equal to the average consumer non-durables industry P/E ratio and above the S&P 500 P/E ratio of 17.7. Shares are up 16.4% year to date as of the close of trading on Monday. Currently there are 10 analysts that rate Estee Lauder Cos a buy, one analyst rates it a sell, and five rate it a hold. TheStreet Ratings rates Estee Lauder Cos as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and expanding profit margins. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value.
- You can view the full Estee Lauder Cos Ratings Report.
- Use our consumer goods section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.